Nrf2 was overexpressed in CD133+ GSCs when compared with CD133− GBM cells, which indicated that the expression of Nrf2 in GSCs was closely correlated with malignant proliferation and differentiation of the GBM. The gene discussed is NFE2L2; the disease is glioblastoma.